This compound is N⁶-(2-hydroxyethyl)adenosine, a modified nucleoside analog of adenosine featuring a 2-hydroxyethyl group at the N6 position of the adenine base. It is used in biochemical and pharmacological research as a selective agonist for adenosine receptors, particularly A2 receptors, to investigate cell signaling pathways, including those involved in vasodilation, neuroprotection, and anti-inflammatory responses. Commonly employed in studies of cardiovascular diseases, neurological disorders, and cancer, it serves as a tool to mimic or modulate adenosine's effects in cellular models. Its enhanced stability compared to adenosine makes it suitable for in vitro assays, receptor binding studies, and drug development targeting purinergic signaling. Due to its niche role, it is not a general commodity but a specialty reagent in biotechnology and medicinal chemistry.